Our Network

Omico is a nationwide network of research and treatment centres that facilitate, support and promote genomic cancer medicine. Central to this is the use of molecular screening for the prevention and treatment of cancer.

New South Wales

Garvan Institute of Medical Research (MoST, RiSC and SMOC+ screening) (ASPiRATION – **open** for screening)

NHMRC Clinical Trials Centre (University of Sydney)

The Kinghorn Cancer Centre (St Vincent’s Hospital, Darlinghurst) (MoST, RiSC and SMOC+)

Chris O’brien Lifehouse (Camperdown) (MoST and RiSC) (ASPiRATION date to be advised – 2021)

St George Hospital (Kogarah) (MoST)

Royal North Shore Hospital (North Sydney) (ASPiRATION – **open** for screening)

Westmead Hospital (Westmead) (ASPiRATION – **open** for screening)

Prince of Wales Hospital (Randwick) (MoST) (opening soon)

Border Medical Oncology (ASPiRATION date to be advised 2021)


Peter MacCallum Cancer Centre (MoST, RiSC and SMOC+) (ASPiRATION – **open** for screening)

Monash Partners Comprehensive Cancer Consortium (MoST screening)

Austin Health (MoST opening soon) (ASPiRATION date to be advised 2021)

St Vincent’s Hospital, Fitzroy (ASPiRATION – **open** for screening)


Royal Hobart Hospital (MoST) (ASPiRATION – **open** for screening)

Australian Capital Territory

Canberra Hospital (MoST) (ASPiRATION date to be advised 2021)


Princess Alexandra Hospital (MoST) (ASPiRATION – **open** for screening)

Royal Brisbane and Women’s Hospital (MoST-LLy)

Prince Charles Hospital (ASPiRATION – **open** for screening)

Pathology Queensland

South Australia

Royal Adelaide Hospital (MoST and SMOC+) (MoST-LLy – opening soon) (ASPiRATION – **open** for screening)

South Australia Pathology

Northern Territory

Royal Darwin Hospital (MoST) (ASPiRATION date to be advised 2021)

Western Australia

Linear Clinical Research Limited (MoST) (ASPiRATION – **open** for screening)

Sir Charles Gairdner Hospital (MoST)


New Zealand

Auckland Hospital (opening soon)

Our Members